Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANTENGENE-B

4.850
+0.0701.46%
Volume:1.46M
Turnover:7.02M
Market Cap:3.29B
PE:-8.61
High:4.940
Open:4.780
Low:4.700
Close:4.780
52wk High:8.160
52wk Low:0.600
Shares:679.00M
HK Float Shares:679.00M
Volume Ratio:1.08
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.563
ROE:-25.98%
ROA:-13.05%
PB:3.92
PE(LYR):-8.61
PS:35.65

Loading ...

Antengene (06996) Publishes Monthly Return for October 2025

Bulletin Express
·
Nov 06

HK Stocks in Action | ANTENGENE-B (06996) Surges Over 6% Following Latest Clinical Results of ATG-022

Stock News
·
Oct 20

Antengene Reports Promising ATG-022 Phase I/II Results in Gastric Cancer at ESMO 2025

Reuters
·
Oct 20

Antengene Corporation Ltd. Reports H1 2025 Revenue Down 12.5% to RMB 53.2 Million; Net Loss Narrows to RMB 76.4 Million

Reuters
·
Sep 29

BOCOM International: Trump's Drug Tariffs Have Limited Impact on Chinese Pharmaceuticals, Recommends Focus on AKESO (09926) and Others

Stock News
·
Sep 29

ANTENGENE-B (06996) Repurchases 29,500 Shares for HK$197,700 on September 16

Stock News
·
Sep 16

ANTENGENE-B (06996) Repurchases 27,000 Shares for HK$199,500 on September 11

Stock News
·
Sep 11

Antengene Files Next Day Disclosure to HKEX Announcing Repurchase of 146,000 Shares at HKD 7.6798 Each

Reuters
·
Sep 10

Hong Kong Stocks Movement | ANTENGENE-B (06996) Surges Over 10% in Afternoon Trading on Share Buyback Plan and ATG-022 Breakthrough Therapy Designation

Stock News
·
Sep 03

BRIEF-Antengene Corp To Repurchase Shares At Maximum Price Of Hk$40 Mln

Reuters
·
Sep 01

Antengene Board Approves HK$40 Million Share Buyback; Shares Jump 7%

MT Newswires Live
·
Sep 01

ANTENGENE-B (06996) Plans to Repurchase Shares Worth Up to HK$40 Million

Stock News
·
Sep 01

Antengene Corporation Ltd. Announces Intention for Share Repurchase Up to HK$40 Million

Reuters
·
Sep 01

Antengene Corp Ltd - to Repurchase Shares at Maximum Price of HK$40 Mln

THOMSON REUTERS
·
Sep 01

Hong Kong Stock Alert | ANTENGENE-B (06996) Surges Nearly 14% in Early Trading as ATG-022 Competitiveness Expected to Strengthen, Institutions Raise Mid-to-Long Term and Peak Sales Forecasts

Stock News
·
Aug 29

Stock Track | Antengene Soars 13.82% Amid Broader Biotech Rally in Hong Kong

Stock Track
·
Aug 29

HK Movers | Biotech Stocks Surge With Cutia Therapeutics up 14%

Tiger Newspress
·
Aug 29

Antengene Announces 2025 Interim Results With Encouraging Clinical Data and Progress in Tce Platform

THOMSON REUTERS
·
Aug 25

Antengene Narrows Loss in H1

MT Newswires Live
·
Aug 22

ANTENGENE-B (06996) Reports Interim Results with Adjusted Loss of RMB 72.858 Million, Down 52.25% YoY

Stock News
·
Aug 22